Biolargo, Inc. Announces Board and Committee Changes
November 03, 2022 at 06:11 am EDT
Share
On November 1, 2022, the Board of Directors of BioLargo, Inc. (“BioLargo) accepted the resignations of board members John S. Runyan and Kent C. Roberts II, and appointed Linda Park and Christina Bray to the board. Each of Ms. Park and Ms. Bray were appointed to the Audit Committee, Compensation Committee, and Nomination and Corporate Governance Committee.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental segment engaged in selling odor and volatile organic control products and services. Clyra Medical segment develops and sells medical products based on its technologies. BLEST segment provides professional engineering services on a time and materials basis for outside clients and supports its internal operations as needed. Its Canada segment is the main hub of its scientists researching and developing its technologies. Its BETI segment is engaged in developing its proprietary battery technology. BEST segment manages the sales and distribution of its water treatment products and related services.
BIOLARGO, INC. 
